These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15885465)

  • 1. Applicability of anti-neovascular therapy to drug-resistant tumor: suppression of drug-resistant P388 tumor growth with neovessel-targeted liposomal adriamycin.
    Shimizu K; Asai T; Fuse C; Sadzuka Y; Sonobe T; Ogino K; Taki T; Tanaka T; Oku N
    Int J Pharm; 2005 May; 296(1-2):133-41. PubMed ID: 15885465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
    Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
    J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes.
    Katanasaka Y; Ida T; Asai T; Maeda N; Oku N
    Int J Pharm; 2008 Aug; 360(1-2):219-24. PubMed ID: 18565703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor model.
    Yonezawa S; Asai T; Oku N
    J Control Release; 2007 Apr; 118(3):303-9. PubMed ID: 17275944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neovascular therapy using novel peptides homing to angiogenic vessels.
    Oku N; Asai T; Watanabe K; Kuromi K; Nagatsuka M; Kurohane K; Kikkawa H; Ogino K; Tanaka M; Ishikawa D; Tsukada H; Momose M; Nakayama J; Taki T
    Oncogene; 2002 Apr; 21(17):2662-9. PubMed ID: 11965539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
    Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416.
    Katanasaka Y; Ida T; Asai T; Shimizu K; Koizumi F; Maeda N; Baba K; Oku N
    Cancer Lett; 2008 Nov; 270(2):260-8. PubMed ID: 18555591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic vessel-targeting DDS by liposomalized oligopeptides.
    Asai T; Oku N
    Methods Mol Biol; 2010; 605():335-47. PubMed ID: 20072892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic photodynamic therapy with targeted liposomes.
    Oku N; Ishii T
    Methods Enzymol; 2009; 465():313-30. PubMed ID: 19913174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronopharmacologic cancer treatment with an angiogenic vessel-targeted liposomal drug.
    Shimizu K; Sawazaki Y; Tanaka T; Asai T; Oku N
    Biol Pharm Bull; 2008 Jan; 31(1):95-8. PubMed ID: 18175949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels.
    Ichikawa K; Hikita T; Maeda N; Yonezawa S; Takeuchi Y; Asai T; Namba Y; Oku N
    Biochim Biophys Acta; 2005 May; 1669(1):69-74. PubMed ID: 15843001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
    Asai T; Shimizu K; Kondo M; Kuromi K; Watanabe K; Ogino K; Taki T; Shuto S; Matsuda A; Oku N
    FEBS Lett; 2002 Jun; 520(1-3):167-70. PubMed ID: 12044891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
    J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
    Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
    Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
    J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC.
    Asai T; Miyazawa S; Maeda N; Hatanaka K; Katanasaka Y; Shimizu K; Shuto S; Oku N
    Cancer Sci; 2008 May; 99(5):1029-33. PubMed ID: 18294280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.
    Reichert F; Barak V; Tarshis M; Prindull G; Tarshis E; Ben-Ishay Z
    Eur J Haematol; 2005 Jul; 75(1):41-6. PubMed ID: 15946309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model.
    Abu-Lila A; Suzuki T; Doi Y; Ishida T; Kiwada H
    J Control Release; 2009 Feb; 134(1):18-25. PubMed ID: 19010364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
    Banciu M; Schiffelers RM; Fens MH; Metselaar JM; Storm G
    J Control Release; 2006 Jun; 113(1):1-8. PubMed ID: 16707187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.